The GLP-1 Gold Rush Attracts Predatory Scammers

The explosive growth of the online GLP-1 market—projected to reach $150 billion within five years—has created a breeding ground for consumer fraud. Telehealth platforms are charging patients without consent and refusing refunds through deceptive policies, exploiting critical gaps in regulatory oversight. This widespread abuse highlights how rapidly scaling pharmaceutical services without proper safeguards can devastate vulnerable consumers.